Scientific publications

Cancer Prevention Research, 2026

Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels

Hussain S., Ayoub W., Cruz-Correa M. et al.

Scientific Reports, 2026

Cardiovascular peptide markers are associated with age-related macular degeneration in the Bialystok PLUS general population cohort

Budnik A., Tuchliński J., Lisowski ?. et al.

Science Translational Medicine, 2026

Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17–driven endothelial activation

Karagkouni D., Brake M., Patell R. et al.

Biomedicines, 2026

Adverse Early-Life Factors Associated with Clonal Hematopoiesis of Indeterminate Potential in Later Life

Yu Y., Wang J., Sun Y. et al.

Clinical Cancer Research, 2026

A multicentre phase 2 study of trifluridine/tipiracil in recurrent/metastatic platinum resistant nasopharyngeal carcinomas

Low J., Chong W., Hui E. et al.

Expert Review of Molecular Diagnostics, 2026

Neuro-axonal injury biomarker serum neurofilament light chain is associated with osteoarthritis: a dual-cohort study from NHANES and UK Biobank

Liu M., Ma H., Zhou H. et al.

Kidney Medicine, 2026

Association of Cystatin C- and Creatinine-Based eGFR With Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

Roehm B., Zhang X., Yang J. et al.

Psychiatry Research, 2026

Bayesian colocalization of psychiatric disorder GWAS signals with molecular quantitative trait loci highlights histone involvement and neuroimmune dysregulation in pathogenesis

Ryu J., Lee C.

Nature Medicine, 2026

Plasma proteomic signatures of cellular aging predict human disease

Ding D., Bot V., Chen K. et al.

Eurasia Journal of Science and Technology, 2026

PLASMA PROTEIN LEVEL RATIOS IDENTIFY NOVEL CIRCULATING TARGETS ASSOCIATED WITH STROKE RISK

Wang Q., Jin T., Gu J. et al.

Annals of the Rheumatic Diseases, 2026

Longitudinal profiling reveals immune dynamics and distinct plasma cell signatures during B-cell depletion in IgG4-related disease

Kim H., Kim M., Kim S. et al.

Journal of the National Cancer Center, 2026

Systemic inflammatory protein signatures associated with gastric lesion progression and risk of gastric cancer

Yang L., Xu H., Zhang C. et al.

Journal of Global Health, 2026

Plasma proteomic signatures predict incident benign prostatic hyperplasia: a prospective cohort study of 20 996 men

Li H., Zhang Y., Chen L. et al.

Cardiovascular Diabetology, 2026

Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3

Chen X., Tang H., Xu Z. et al.

Frontiers in Cardiovascular Medicine, 2026

Extracorporeal cardiac shock wave therapy modulates post-infarction neovascularization via CAC-mediated pro-angiogenic effects and modulation of the S100A4/CSF2/FOXO1 protein network

Li Y., Li H., Liu C. et al.

Psychiatry Research, 2026

Multi-omics integration identifies cell-type-specific CISD1 and QDPR as druggable regulators linking hepatocellular carcinoma and major depressive disorder

Sun L., Bi J., Sun J.

Journal of Extracellular Vesicles, 2026

Intranasal Delivery of Bacterial Extracellular Vesicles Enables RNA Cargo Entry Into the Brain

Ha J., Kim S., Choi S. et al.

Communications Medicine, 2026

Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera

Li X., An W., Wang X. et al.

Molecular Psychiatry, 2026

Plasma proteomics of sleep traits reveals systemic immune-metabolic pathways and genetically prioritized proteins

Chen H., Wang X., Chen W. et al.

Journal of Inflammation Research, 2026

Identification of Biomarker in Kidney Stone Disease by Integrating Transcriptomics and Olink Proteomics: A Case–Control Study

Wang N., Zhou B., Xu C. et al.